XML 26 R9.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Feb. 01, 2025
Feb. 03, 2024
Jan. 28, 2023
Operating activities:      
Net income $ 593,476 $ 738,847 $ 891,637
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of property and other deferred costs 179,522 181,182 190,030
Deferred income taxes (8,992) (17,724) (15,299)
Gain on disposal of assets (475) (6,053) (21,047)
Gain from insurance proceeds     (160)
Accrued interest on short-term investments (11,757) (5,679) (3,206)
Changes in operating assets and liabilities:      
Decrease (increase) in accounts receivable 4,847 (3,595) (17,175)
(Increase) decrease in merchandise inventories (78,048) 26,209 (40,030)
Decrease (increase) in other current assets 2,277 (7,819) (5,359)
Increase in other assets (787) (4,678) (1,161)
Increase (decrease) in trade accounts payable and accrued expenses and other liabilities 36,471 (22,492) (28,582)
(Decrease) increase in income taxes payable (2,407) 5,392 (1,257)
Net cash provided by operating activities 714,127 883,590 948,391
Investing activities:      
Purchase of property and equipment and capitalized software (104,552) (132,944) (120,105)
Proceeds from disposal of assets 703 6,328 25,062
Proceeds from insurance   4,477 4,886
Purchase of short-term investments (696,734) (295,354) (245,696)
Proceeds from maturities of short-term investments 530,852 301,899 100,000
Net cash used in investing activities (269,731) (115,594) (235,853)
Financing activities:      
Principal payments on long-term debt     (44,800)
Cash dividends paid (413,795) (338,629) (271,313)
Purchase of treasury stock (121,034) (281,411) (452,853)
Net cash used in financing activities (534,829) (620,040) (768,966)
(Decrease) increase in cash and cash equivalents and restricted cash (90,433) 147,956 (56,428)
Cash and cash equivalents and restricted cash, beginning of period 808,287 660,331 716,759
Cash and cash equivalents and restricted cash, end of period 717,854 808,287 660,331
Non-cash transactions:      
Accrued capital expenditures 6,783 6,219 5,155
Stock awards 4,176 4,509 6,186
Accrued purchases of treasury stock and excise taxes 1,168 2,770  
Lease assets obtained in exchange for new operating lease liabilities $ 2,852 $ 20,477 $ 3,660